XML 67 R5.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
In Thousands, unless otherwise specified
 3 Months Ended
Apr. 05, 2014
Mar. 30, 2013
Operating Activities:    
Net income $ 69,161 $ 73,980
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation, amortization and accretion 23,377 18,758
Stock-based compensation 4,978 2,546
Decrease in allowance for returns-net of inventory in transit (1,525) (238)
(Gain) loss on disposal of assets (31) 266
Impairment losses 282 0
Gain on equity method investment 0 (6,410)
Decrease in allowance for doubtful accounts (1,063) (4,202)
Excess tax benefits from stock-based compensation (938) (4,082)
Deferred income taxes and other (440) 8,292
Changes in operating assets and liabilities:    
Accounts receivable 167,760 99,403
Inventories (32,002) (11,507)
Prepaid expenses and other current assets (38,439) (14,721)
Accounts payable (17,879) (20,369)
Accrued expenses (80,095) (49,000)
Income taxes payable 3,829 (6,813)
Net cash provided by operating activities 96,975 85,903
Investing Activities:    
Additions to property, plant and equipment (21,505) (19,485)
Increase in intangible and other assets (2,162) (723)
Net change in restricted cash (3) 452
Business acquisitions-net of cash acquired 0 (15,165)
Net cash used in investing activities (23,670) (34,921)
Financing Activities:    
Acquisition of common stock (119,715) (61,188)
Distribution of noncontrolling interest earnings and other (5,391) (4)
Excess tax benefits from stock-based compensation 938 4,082
Debt borrowings 196,200 218,098
Debt payments (162,456) (142,718)
Proceeds from exercise of stock options 759 1,991
Net cash (used in) provided by financing activities (89,665) 20,261
Effect of exchange rate changes on cash and cash equivalents (701) (7,083)
Net (decrease) increase in cash and cash equivalents (17,061) 64,160
Cash and cash equivalents:    
Beginning of period 320,479 177,236
End of period $ 303,418 $ 241,396